DrugJun 20, 2018
Shadow Holdings DBA Bocchi Labs X-Jow (menthol USP) Pain Gel, 1.25% recall — FDA D-0858-2018
CGMP Deviations: products may be contaminated with bacteria.
Class IIFDA: TerminatedShadow Holdings DBA Bocchi Labs
Recall history in this database
Classification mix: Class II: 4.
DrugJun 20, 2018
Shadow Holdings DBA Bocchi Labs Acne Shave 3 Step Shaving System, contains one tube Acne recall — FDA D-0861-2018
CGMP Deviations: products may be contaminated with bacteria.
Class IIFDA: TerminatedShadow Holdings DBA Bocchi Labs
DrugJun 20, 2018
Shadow Holdings DBA Bocchi Labs Acne Shave Post-Shave Moisturizer (salicylic acid), 0.5% recall — FDA D-0859-2018
CGMP Deviations: products may be contaminated with bacteria.
Class IIFDA: TerminatedShadow Holdings DBA Bocchi Labs
DrugJun 20, 2018
Shadow Holdings DBA Bocchi Labs Acne Shave (salicylic acid) Shave Cream Acne Shield, 0.5% recall — FDA D-0860-2018
CGMP Deviations: products may be contaminated with bacteria.
Class IIFDA: TerminatedShadow Holdings DBA Bocchi Labs
Understanding this recall history
This page summarizes recall records in which the official source identifies Shadow Holdings DBA Bocchi Labs as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.